PortfoliosLab logoPortfoliosLab logo
ISIN
US6404911066
CUSIP
640491106
IPO Date
Aug 23, 1989

Highlights

Market Cap
$1.90B
Enterprise Value
$1.74B
EPS (TTM)
-$2.80
Total Revenue (TTM)
$870.54M
Gross Profit (TTM)
$346.99M
EBITDA (TTM)
-$474.40M
Year Range
$4.56 - $11.43
Target Price
$11.00
ROA (TTM)
-18.12%
ROE (TTM)
-28.96%

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Neogen Corporation

Performance

NEOG Performance Chart

Neogen Corporation (NEOG) is up 25.2% since the beginning of the year. At $9 per share, NEOG is trading 23.4% below its 52-week high of $11. Investors who bought $1,000 worth of NEOG shares 5 years ago would now be looking at an investment worth $194.


Loading charts...

S&P 500 Index

Returns By Period

Neogen Corporation (NEOG) has returned 25.18% so far this year and 53.78% over the past 12 months. Over the last ten years, NEOG has returned -7.53% per year, falling short of the S&P 500 Index benchmark, which averaged 13.75% annually.


Neogen Corporation

1D
-1.91%
1M
-8.18%
YTD
25.18%
6M
47.80%
1Y
53.78%
3Y*
-22.10%
5Y*
-27.97%
10Y*
-7.53%

Benchmark (S&P 500 Index)

1D
0.13%
1M
5.25%
YTD
11.16%
6M
11.43%
1Y
28.20%
3Y*
21.12%
5Y*
12.66%
10Y*
13.75%
*Multi-year figures are annualized to reflect compound growth (CAGR)

NEOG Monthly Returns History

Based on dividend-adjusted daily data since Feb 10, 1994, NEOG's average daily return is +0.07%, while the average monthly return is +1.32%. At this rate, an investment would double in approximately 4.4 years.

Historically, 55% of months were positive and 45% were negative. The best month was Jan 2001 with a return of +58.5%, while the worst month was Apr 2025 at -41.8%. The longest winning streak lasted 11 consecutive months, and the longest losing streak was 8 months.

On a daily basis, NEOG closed higher 47% of trading days. The best single day was Jan 8, 2026 with a return of +31.6%, while the worst single day was Apr 9, 2025 at -28.7%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202646.21%9.88%-17.28%1.18%-4.57%-2.45%25.18%
2025-5.60%-12.30%-13.73%-41.75%16.04%-18.43%-2.72%23.66%-0.70%8.06%-3.08%16.89%-42.42%
2024-22.92%10.90%-8.20%-21.86%6.65%18.86%8.96%1.29%-2.55%-15.05%-0.70%-14.39%-39.63%
202340.58%-17.38%4.69%-7.02%1.57%24.36%6.62%-0.30%-19.81%-19.69%13.97%18.50%32.04%
2022-19.69%-2.11%-13.61%-14.40%0.23%-8.96%-3.99%-9.64%-33.16%-5.51%25.45%-8.03%-66.46%
20211.98%1.30%8.51%8.01%-3.85%-0.25%-5.39%0.51%-0.80%-2.58%-5.15%13.16%14.53%

Benchmark Metrics

Neogen Corporation has an annualized alpha of 11.13%, beta of 0.69, and R2 of 0.08 versus S&P 500 Index. Calculated based on daily prices since February 11, 1994.

  • Beta of 0.69 may look defensive, but with R2 of 0.08 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
  • R2 of 0.08 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
11.13%
Beta
0.69
0.08
Upside Capture
102.14%
Downside Capture
104.97%

Return for Risk

Risk / Return Rank

NEOG ranks 70 for risk / return — better than 70% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.


NEOG Risk / Return Rank: 7070
Overall Rank
NEOG Sharpe Ratio Rank: 6868
Sharpe Ratio Rank
NEOG Sortino Ratio Rank: 6767
Sortino Ratio Rank
NEOG Omega Ratio Rank: 6868
Omega Ratio Rank
NEOG Calmar Ratio Rank: 7373
Calmar Ratio Rank
NEOG Martin Ratio Rank: 7272
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Neogen Corporation (NEOG) and compare them to S&P 500 Index.


NEOGBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

0.87

2.39

-1.52

Sortino ratio

Return per unit of downside risk

1.63

3.25

-1.63

Omega ratio

Gain probability vs. loss probability

1.22

1.43

-0.22

Calmar ratio

Return relative to maximum drawdown

1.95

3.11

-1.16

Martin ratio

Return relative to average drawdown

4.15

14.38

-10.23

Dividends

Dividend History


Neogen Corporation doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the Neogen Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Neogen Corporation was 90.92%, occurring on Apr 17, 2025. The portfolio has not yet recovered.

The current Neogen Corporation drawdown is 81.90%.


Related event

Drawdown

Fall

Recovery

Underwater

2025 selloff2025
-90.92%Apr 2025
3y 12mo
5y 1moApr 2021 - now
1999 bear market1999
-65.52%Dec 1999
2y 2mo1y 4mo
3y 7moOct 1997 - Apr 2001
Dot-com crash2000–2002
-54.39%Aug 2002
9mo 9d1y 4mo
2y 1moNov 2001 - Dec 2003
1996 bear market1996
-50.65%Jan 1996
1y 2mo1y 7mo
2y 10moOct 1994 - Aug 1997
Rate-hike selloffLate 2018
-45.37%Dec 2018
3mo 8d2y 3mo
2y 7moSep 2018 - Apr 2021

Drawdown Indicators


NEOGBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-90.92%

-56.78%

-34.14%

Max Drawdown (1Y)

Largest decline over 1 year

-27.71%

-9.10%

-18.61%

Max Drawdown (3Y)

Largest decline over 3 years

-81.59%

-18.90%

-62.69%

Max Drawdown (5Y)

Largest decline over 5 years

-90.59%

-25.43%

-65.16%

Max Drawdown (10Y)

Largest decline over 10 years

-90.92%

-33.92%

-57.00%

Current Drawdown

Current decline from peak

-81.90%

0.00%

-81.90%

Average Drawdown

Average peak-to-trough decline

-26.86%

-10.72%

-16.14%

Ulcer Index

Depth and duration of drawdowns from previous peaks

13.00%

1.97%

+11.03%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Neogen Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Neogen Corporation is priced in the market compared to other companies in the Diagnostics & Research industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for NEOG relative to other companies in the Diagnostics & Research industry. Currently, NEOG has a P/S ratio of 2.2. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for NEOG in comparison with other companies in the Diagnostics & Research industry. Currently, NEOG has a P/B value of 0.9. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with NEOG

Add Neogen Corporation to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with NEOG